$YGYI Market Trends Toward New Normal, Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Nov. 21, 2018 – In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Transcat, Inc. (NASDAQ:TRNS), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), Youngevity International Inc. (NASDAQ:YGYI), Aquestive Therapeutics, Inc. (NASDAQ:AQST), TORM PLC (NASDAQ:TRMD), and Transglobe Energy Corp (NASDAQ:TGA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TRNS DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRNS
BTAI DOWNLOAD: http://Fundamental-Markets.com/register/?so=BTAI
YGYI DOWNLOAD: http://Fundamental-Markets.com/register/?so=YGYI
AQST DOWNLOAD: http://Fundamental-Markets.com/register/?so=AQST
TRMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRMD
TGA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TGA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Transcat, Inc. (NASDAQ:TRNS), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), Youngevity International Inc. (NASDAQ:YGYI), Aquestive Therapeutics, Inc. (NASDAQ:AQST), TORM PLC (NASDAQ:TRMD), and Transglobe Energy Corp (NASDAQ:TGA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

—————————————–

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

—————————————–

TRANSCAT, INC. (TRNS) REPORT OVERVIEW

Transcat’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Transcat reported revenue of $38.88MM vs $35.93MM (up 8.22%) and analysts estimated basic earnings per share $0.21 vs $0.11 (up 90.91%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Transcat reported revenue of $155.14MM vs $143.90MM (up 7.81%) and analysts estimated basic earnings per share $0.83 vs $0.65 (up 27.69%). Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $1.13 and is expected to report on May 28th, 2019.

To read the full Transcat, Inc. (TRNS) report, download it here: http://Fundamental-Markets.com/register/?so=TRNS

—————————————–

BIOXCEL THERAPEUTICS, INC. (BTAI) REPORT OVERVIEW

BioXcel Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$1.94 and is expected to report on February 8th, 2019.

To read the full BioXcel Therapeutics, Inc. (BTAI) report, download it here: http://Fundamental-Markets.com/register/?so=BTAI

—————————————–

YOUNGEVITY INTERNATIONAL INC. (YGYI) REPORT OVERVIEW

Youngevity International’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Youngevity International reported revenue of $39.08MM vs $44.40MM (down 11.97%) and analysts estimated basic earnings per share -$0.46 vs -$0.05. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Youngevity International reported revenue of $165.70MM vs $162.67MM (up 1.86%) and analysts estimated basic earnings per share -$0.65 vs -$0.02. Analysts expect earnings to be released on April 4th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Youngevity International Inc. (YGYI) report, download it here: http://Fundamental-Markets.com/register/?so=YGYI

—————————————–

AQUESTIVE THERAPEUTICS, INC. (AQST) REPORT OVERVIEW

Aquestive Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$0.99 and is expected to report on February 5th, 2019.

To read the full Aquestive Therapeutics, Inc. (AQST) report, download it here: http://Fundamental-Markets.com/register/?so=AQST

—————————————–

TORM PLC (TRMD) REPORT OVERVIEW

TORM’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, TORM reported revenue of $140.40MM vs $155.80MM (down 9.88%) and analysts estimated basic earnings per share -$0.34 vs -$0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TORM reported revenue of $656.99MM vs $680.14MM (down 3.40%) and analysts estimated basic earnings per share $0.04 vs -$2.30. Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full TORM PLC (TRMD) report, download it here: http://Fundamental-Markets.com/register/?so=TRMD

—————————————–

TRANSGLOBE ENERGY CORP (TGA) REPORT OVERVIEW

Transglobe Energy’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Transglobe Energy reported revenue of $42.63MM vs $44.85MM (down 4.95%) and analysts estimated basic earnings per share -$0.17 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Transglobe Energy reported revenue of $148.57MM vs $63.81MM (up 132.85%) and analysts estimated basic earnings per share -$1.09 vs -$1.21. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.08.

To read the full Transglobe Energy Corp (TGA) report, download it here: http://Fundamental-Markets.com/register/?so=TGA

—————————————–

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.